18th Jun 2010 16:55
18 June 2010 Verona Pharma Plc ("Verona" or "the Company") Grant of Options
Verona Pharma (AIM: VRP), the drug discovery company, announces that on 15 June 2010, the Remuneration Committee of the Company granted options over ordinary shares of 0.1 pence ("Ordinary Shares") to Dr. Patrick Humphrey, a Non-Executive Director of the Company.
Dr. Patrick Humphrey has been granted options over 500,000 Ordinary Shares at an exercise price of 9 pence per share and these options will vest as to one third on each of the three anniversaries following the date of grant. The options will have an exercise period of five years from the date of grant and will lapse immediately thereafter. The options have been granted in recognition of Dr. Humphrey's significant and ongoing contribution to the development of the Company.
Following this grant Dr Patrick Humphrey holds options over 1,500,000 OrdinaryShares. --END-- Enquiries
For more information please contact:
Professor Clive Page 020 7863 3300 Chairman, Verona Pharma plc
Barry Saint / Tim Redfern / Esther Lee 020 7071 4300 Evolution Securities Limited (Nominated adviser and broker) Gemma O'Hara/Siobhra Murphy 020 7562 3350 Bishopsgate Communications 078 2577 3710
vendorRelated Shares:
VRP.L